- Home
- Products
Fotivda (Tivozanib)
Fotivda (Tivozanib)
- Medicine Name: Fotivda
- Generic Name: Tivozanib
- Dosage Form & Strength: Capsules – 1.34 mg and 0.89 mg
- Manufactured By: AVEO Pharmaceuticals, Inc.
Fotivda is a kinase inhibitor used for the treatment of relapsed or refractory advanced renal cell carcinoma (RCC) in adult patients who have received two or more prior systemic therapies.
Recommended Dosage:
- 1.34 mg once daily for 21 days followed by 7 days off
- Repeat in 28-day cycles until disease progression or unacceptable toxicity
- Swallow whole with water, with or without food
- Do not open, crush, or split the capsule
- If a dose is missed, resume at the next scheduled time (no double dosing)
Hypertension: Monitor blood pressure regularly during treatment
Dysphonia & Hypothyroidism: May occur in treated patients; regular thyroid function monitoring advised
Hepatotoxicity & Fatigue: Common adverse events; adjust dosage if needed
Fetal Harm Risk: Avoid during pregnancy. Use effective contraception during treatment and for a period after the last dose
Breastfeeding Restriction: Not recommended during treatment and for some time after due to potential serious adverse effects
Documents Required to Import Fotivda to India:
- Valid medical prescription
- Diagnostic reports supporting RCC
- Government-issued ID of the patient
Order Confirmation:
- Confirmed only after receipt of complete documentation and import permit (if applicable)
Availability in India & Globally:
Available in Mumbai, Delhi, Chennai, Hyderabad, Bangalore, Kolkata, Ahmedabad, Pune, and other Indian cities. Also available globally under the Named Patient Program.
To Enquire or Order:
- 📞 Call/WhatsApp: +91-99675 15602
- 📧 Email: info@globalraremeds.com
Global Rare Meds sources Fotivda from certified suppliers across the USA, Europe, Canada, and Australia. Every order is:
- Dispensed by licensed pharmacists
- Quality-checked and packed at our Ambernath, Thane District fulfillment center
- Dispatched safely and legally worldwide
We ensure compliance with Indian import regulations and guarantee reliable access.
What is the generic name of Fotivda®?
Tivozanib
Who manufactures Fotivda®?
AVEO Pharmaceuticals, Inc.
Is Fotivda® FDA approved?
Yes, approved on March 10, 2021
What dosage forms are available?
Capsules: 1.34 mg and 0.89 mg for oral use
What are common side effects?
Fatigue, cough, hypertension, decreased appetite, nausea, hypothyroidism, diarrhea, stomatitis, dysphonia
How much does Fotivda® cost in India?
Pricing is variable. Contact +91-99675 15602 or email info@globalraremeds.com for the latest rate
Storage conditions?
Store between 20°C to 25°C (68°F to 77°F); excursions permitted between 15°C to 30°C
Can I buy Fotivda® online from India?
Yes, through Global Rare Meds under the legal Named Patient Import Program
Contact Patient Support
If you have questions about your order, need assistance with documentation, or require support with medicine availability, our GlobalRareMeds Patient Support Team is here to help. We aim to respond within 24 hours, Monday to Friday, between 9:00 AM and 10:00 AM IST.
info@globalraremeds.com
Phone
+91 99675 15602
+91 99675 15602
Disclaimer
All trademarks, brands, and product names featured on this website are the property of their respective owners. GlobalRareMeds does not claim ownership or affiliation unless explicitly stated. Our role is to provide reliable and transparent access to difficult-to-source medicines through named-patient import services, based on valid prescriptions and legal requirements.
The product-related content on this website is shared to the best of our knowledge, compiled from publicly available sources and regulatory documents. However, GlobalRareMeds does not guarantee the accuracy, completeness, or timeliness of this information. We strongly recommend that all medical decisions, including usage and dosage, be made only in consultation with the prescribing doctor. GlobalRareMeds assumes no responsibility for consequences arising from reliance on this information without appropriate medical guidance
